Company Overview and News

 
Sierra Metals: Big Improvement Across The Board

2018-09-06 seekingalpha
Production went significantly up and costs of production were cut to the level where the company is able to deliver free cash flow, even at today's depressed metal prices.
SMT DBEXF SMTS

 
Sierra Metals, Inc. 2018 Q2 - Results - Earnings Call Slides

2018-08-14 seekingalpha
The following slide deck was published by Sierra Metals, Inc. in conjunction with their 2018 Q2 earnings call.
SMT DBEXF SMTS

 
Sierra Metals Sees Hammer Chart Pattern: Time to Buy?

2018-07-05 zacks
Sierra Metals Inc. (SMTS - Free Report) has been struggling lately, but the selling pressure may be coming to an end soon. That is because SMTS recently saw a Hammer Chart Pattern which can signal that the stock is nearing a bottom.
SMT DB BLT DBEXF BHP BHPBF BBL SMTS BHP BHPLF DLPH

30
BHP Billiton (BHP) JV Plans to Divest Gregory Crinum Mine

2018-06-01 zacks
BHP Billiton Limited’s (BHP - Free Report) joint-venture (JV) business with Mitsubishi Development Pty Ltd (Mitsubishi) — BHP Billiton Mitsubishi Alliance (BMA) — has signed an agreement to spin-off its Gregory Crinum Mine to Sojitz Corporation, for A$100 million. Share price of BHP Billiton was nearly flat at $49.78, post the divestiture news’ announcement on May 30, 2018. Queensland’s hard coking coal mine — Gregory Crinum — is situated 60 km north east of Emerald, in the Bowen Basin.
GGTCF BLT BHPBF SZHFF SMT AUG DBEXF BHP BBL BHP SMTS BHPLF AUG

 
Sierra Metals' (SMTS) CEO Igor Gonzales on Q1 2018 Results - Earnings Call Transcript

2018-05-11 seekingalpha
Good morning. My name is Jessie, and I’ll be your conference operator today. At this time, I would like to welcome everyone to Sierra Metals' First Quarter 2018 Financial Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions]. Thank you.
SMT DBEXF SMTS

1
Sierra Metals Is Heading In The Right Direction

2018-05-11 seekingalpha - 1
A few days ago Sierra Metals released its Q1 2018 report; in my opinion, it was outstanding.
SMT DBEXF SMTS

1
Sierra Metals, Inc. 2018 Q1 - Results - Earnings Call Slides

2018-05-11 seekingalpha - 1
The following slide deck was published by Sierra Metals, Inc. in conjunction with their 2018 Q1 earnings call.
SMT DBEXF SMTS

1
Sierra Metals - A Turnaround Year

2018-03-27 seekingalpha
Generally, for many years it was a single-mine company but this year we should see big improvements at Sierra's Mexican operations.
SMT DBEXF KGI KGI.DB.A KGI.DB SMTS KL

4
Sierra Metals' (SMTS) Igor Gonzales on Q4 2017 Results - Earnings Call Transcript

2018-03-26 seekingalpha
Good day. My name is Jack, and I will be your conference operator today. At this time, I would like to welcome everyone to the Sierra Metals' Fourth Quarter and Year End 2017 Financial Results. All lines have been placed on mute to prevent any background noise. After the speakers' remarks there will be a question-and-answer session. [Operator Instructions] Thank you.
SMT DBEXF MALRY SMTS MALRF MIN

 
BRIEF-Sierra Metals Reports Q4 Revenue of $51.2 Mln

2018-03-22 reuters
* SIERRA METALS INC - QTRLY ZINC EQUIVALENT POUNDS PRODUCED 47.29 MILLION VERSUS 51.23 MILLION LAST YR
SMT DBEXF SMTS

 
BRIEF-Sierra Metals Announces Strike Action From A Fraction Of Workers At The Yauricocha Mine, Peru

2018-03-16 reuters
* SIERRA METALS ANNOUNCES STRIKE ACTION FROM A FRACTION OF WORKERS AT THE YAURICOCHA MINE, PERU
SMT DBEXF SMTS

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to TSX:SMT / Sierra Metals Inc on message board site Silicon Investor.

SMTI: SMTEK International, Inc. SMTI: SMTEK International, Inc. SMTI: SMTEK International, Inc. SmarTire SMTR - Diamond in the Rough? SmarTire SMTR - Diamond in the Rough? SmarTire SMTR - Diamond in the Rough?
SMTC Corporation (SMTX) SMTC Corporation (SMTX) SMTC Corporation (SMTX) SEMITOOL (SMTL):Is it a hold? SEMITOOL (SMTL):Is it a hold? SEMITOOL (SMTL):Is it a hold?
Semtech (Nasdaq:SMTC) Semtech (Nasdaq:SMTC) Semtech (Nasdaq:SMTC) SMTF SMTF SMTF
SmarTire (SMTR) -- Tire monitoring for saftey and economy SmarTire (SMTR) -- Tire monitoring for saftey and economy SmarTire (SMTR) -- Tire monitoring for saftey and economy Fileneu0027s Basement(BSMT) Fileneu0027s Basement(BSMT) Fileneu0027s Basement(BSMT)
Sumitomo Electric - OTC - SMTOY Sumitomo Electric - OTC - SMTOY Sumitomo Electric - OTC - SMTOY To SMTV or not to SMTV? To SMTV or not to SMTV? To SMTV or not to SMTV?